OTC Pharmaceuticals - Estonia | Statista Market Forecast

The revenue generated in the OTC Pharmaceuticals market in Estonia is projected to reach US$117.50m in 2024.
It is expected that the market will experience an annual growth rate of 5.89% (CAGR 2024-2029).
Among the various markets within the market, Other OTC Pharmaceuticals holds the largest market share, with a volume of US$26.59m in 2024.
When compared globally, the United States generates the highest revenue, amounting to US$41.24bn in 2024.
In terms of per capita revenue, in Estonia generates US$89.06 per person in 2024.
Furthermore, it is estimated that online sales will contribute 2.35% of the total revenue in the OTC Pharmaceuticals market by 2024.
The demand for OTC Pharmaceuticals in Estonia is driven by a growing health-conscious population seeking self-medication options.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Estonia has been experiencing steady growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences: Estonian consumers have shown a growing preference for self-care and convenience, leading to an increased demand for over-the-counter (OTC) pharmaceutical products. This trend can be attributed to several factors, including the busy lifestyles of modern consumers, a desire for immediate relief from minor ailments, and a growing awareness of the benefits of self-medication. Additionally, the availability of a wide range of OTC products in pharmacies and supermarkets has made it easier for consumers to access these medications without a prescription.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Estonia is the growing popularity of natural and herbal remedies. Consumers are increasingly seeking out products that are perceived as more natural and less likely to have side effects. This trend is in line with the global shift towards natural and alternative medicine, as consumers become more conscious of their health and well-being. As a result, manufacturers are introducing a wider range of natural and herbal OTC products to cater to this demand.Another trend in the market is the increasing focus on preventive healthcare. Estonian consumers are becoming more proactive in managing their health and are willing to invest in OTC products that can help prevent or alleviate common health issues. This trend is driven by a growing awareness of the importance of preventive measures, such as maintaining a healthy lifestyle, taking supplements, and using OTC medications to prevent the onset of illnesses.

Local special circumstances: Estonia has a well-developed healthcare system with a high level of accessibility to healthcare services. This, combined with a high level of education and awareness among the population, has contributed to the growth of the OTC Pharmaceuticals market. The government has also implemented policies to promote self-care and the use of OTC medications, further driving the market growth.

Underlying macroeconomic factors: The overall economic stability and increasing disposable income in Estonia have also played a role in the growth of the OTC Pharmaceuticals market. As the economy continues to grow, consumers have more purchasing power and are willing to spend on healthcare products, including OTC medications. Additionally, the aging population in Estonia is driving the demand for OTC products, as older individuals are more likely to require medication for chronic conditions and age-related ailments.In conclusion, the OTC Pharmaceuticals market in Estonia is experiencing growth due to changing customer preferences, including a preference for self-care, natural remedies, and preventive healthcare. The local special circumstances, such as a well-developed healthcare system and government policies promoting self-care, have also contributed to the market growth. Furthermore, underlying macroeconomic factors, such as economic stability and increasing disposable income, have driven the demand for OTC medications in Estonia.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.